Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study

Donor-derived cell-free DNA (dd-cfDNA) is used as a biomarker for detection of antibody-mediated rejection (ABMR) and other forms of graft injury. Another potential indication is guidance of immunosuppressive therapy when no therapeutic drug monitoring is available. In such situations, detection of...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmanodja, Bilgin, Akifova, Aylin, Oellerich, Michael, Beck, Julia, Bornemann-Kolatzki, Kirsten, Schütz, Ekkehard, Budde, Klemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051604/
https://www.ncbi.nlm.nih.gov/pubmed/36983437
http://dx.doi.org/10.3390/jcm12062437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051604/
https://www.ncbi.nlm.nih.gov/pubmed/36983437
http://dx.doi.org/10.3390/jcm12062437

Ejemplares similares